Pausing Enhanced Pandemic Pathogen Research Act of 2023
- Last Action
- 4/7/2023
Actions
- 2023-04-07Referred to the Subcommittee on Health.
- 2023-03-28Referred to the House Committee on Energy and Commerce.
- 2023-03-28Introduced in House
- 2023-03-28Introduced in House
CRS Summary
As of 2023-03-28 (00)
Pausing Enhanced Pandemic Pathogen Research Act of 2023
This bill generally prohibits the National Institutes of Health from conducting or supporting gain-of-function research through March 30, 2028. The bill defines gain-of-function research as any research that could enhance the transmissibility, virulence, or pathogenicity of any pathogen or non-pathogen agent in a way that could lead to (1) moderate or high transmissibility, virulence, or pathogenicity in human populations; (2) significant morbidity or mortality in humans; or (3) severe threats to public health or U.S. national security.
The prohibition does not apply to the characterization or testing of naturally occurring influenza virus or coronavirus unless the characterization or testing could increase viral pathogenicity or transmissibility.
Cosponsors (5)
- Henry Cuellar (D-TX)
- Mike Gallagher (R-WI)
- Josh Brecheen (R-OK)
- Guy Reschenthaler (R-PA)
- Debbie Lesko (R-AZ)
Subjects
- Infectious and parasitic diseases
- Medical research
- National Institutes of Health (NIH)
- Research administration and funding
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.